Revolutionary four-biomarker panel offers hope for early ovarian cancer detection
Can't see this email? View it online
   
  Ovarian Cancer  
  The latest ovarian cancer news from News Medical  
 New analysis of cancer cells identifies 370 targets for smarter, personalized treatmentsNew analysis of cancer cells identifies 370 targets for smarter, personalized treatments
 
A new, systematic analysis of cancer cells identifies 370 candidate priority drug targets across 27 cancer types, including breast, lung and ovarian cancers.
 
 
 Revolutionary four-biomarker panel offers hope for early ovarian cancer detectionRevolutionary four-biomarker panel offers hope for early ovarian cancer detection
 
The biomarker CA125 for early detection of ovarian cancer.
 
   Big data analysis paves way for personalized ovarian cancer treatmentBig data analysis paves way for personalized ovarian cancer treatment
 
A recent study led by Hidenori Machino at the RIKEN Center for Advanced Intelligence Project (AIP) and the National Cancer Center Research Institute in Japan used a big data multi-omics analysis to examine changes in gene expression as cells from human fallopian tubes become cancerous.
 
   Research discovers fibronectin's role in BRAF-mutant thyroid cancer resistanceResearch discovers fibronectin's role in BRAF-mutant thyroid cancer resistance
 
New research overseen by University of Colorado Cancer Center member Rebecca Schweppe, PhD, could lead to improved treatment for people with thyroid cancer characterized by a mutation in the BRAF gene -; a mutation also responsible for some types of melanoma, colorectal cancer, leukemia, lymphoma, and ovarian cancer.
 
 Study uncovers new weapon against PARP inhibitor-resistant ovarian cancers
 
Study uncovers new weapon against PARP inhibitor-resistant ovarian cancersA new editorial paper was published in Oncotarget's Volume 14 on December 22, 2023, entitled, "One more step toward treatment of PARP inhibitor-resistant ovarian cancers."
 
 
 Community health workers champion genetic literacy for minorities
 
Community health workers champion genetic literacy for minoritiesChanges to DNA, known as mutations, can increase the likelihood of developing cancer. Specifically, people with mutations in their BRCA 1 and 2 genes are substantially more likely to develop hereditary breast and ovarian cancers. But how do people know if they have these mutations?